Price target
0.870.000.00%
The 3 analysts offering 1 year price forecasts for RLMD have a max estimate of — and a min estimate of —.
Analyst rating
Based on 3 analysts giving stock ratings to RLMD in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
RLMD EPS for the last quarter is −0.72 USD despite the estimation of −0.68 USD. In the next quarter EPS is expected to reach −0.71 USD. Track more of Relmada Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Relmada Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Relmada Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, RLMD price target is 0.87 USD with a max estimate of 1.00 USD and a min estimate of 0.60 USD. Check if this forecast comes true in a year, meanwhile watch Relmada Therapeutics, Inc. stock price chart and keep track of the current situation with RLMD news and stock market news.